Active	Status	Sponsor type	Region	Phase	Filter
1 Active 4 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
dihydroergotamine intranasal (STS101) / Shin Nippon Biomedical Labs
ASCEND, NCT04406649: A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine	Completed	3	482	US	Dihydroergotamine, Dihydroergotamine Mesylate	Satsuma Pharmaceuticals, Inc.	Migraine, Migraine With Aura, Migraine Without Aura	01/23	01/23